Sequenom Reaffirms $41M Offer for Exact | GenomeWeb

NEW YORK (GenomeWeb News) — Sequenom today said it plans to try to go ahead with its attempt to buy Exact Sciences for $1.50 a share, or around $41 million, in an all-stock transaction despite Exact's refusal on Monday to accept the offer, which Sequenom put forward at the end of last week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.